Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3
|
pubmed:dateCreated |
1989-10-26
|
pubmed:abstractText |
The aim of our study was to determine in patients over 70 years, the optimal dose of Bromazepam. Seven patients were administered a unique dose of Bromazepam (3 mg), then repeated doses (1.5 mg) every 12 hours for 9 days. Cmax was 42.5 +/- 12 ng/ml in Tmax ranged from 2 to 12 hours after the first dose-concentrations of Bromazepam at steady-state were between 79 and 157 ng/ml. Half life was 30.5 +/- 14.7 hrs for the unique and the repeated doses. Sleeping was noted for concentrations over 40 ng/ml. The dose of 1.5 mg bid is recommended in old patients.
|
pubmed:language |
fre
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
0040-5957
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
44
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
219-22
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:2571196-Administration, Oral,
pubmed-meshheading:2571196-Aged,
pubmed-meshheading:2571196-Aged, 80 and over,
pubmed-meshheading:2571196-Anti-Anxiety Agents,
pubmed-meshheading:2571196-Anxiety,
pubmed-meshheading:2571196-Bromazepam,
pubmed-meshheading:2571196-Drug Evaluation,
pubmed-meshheading:2571196-Female,
pubmed-meshheading:2571196-Humans,
pubmed-meshheading:2571196-Male
|
pubmed:articleTitle |
[Determination of the optimal dose of bromazepam in the elderly].
|
pubmed:publicationType |
Journal Article,
English Abstract,
Research Support, Non-U.S. Gov't
|